Clotrimazole Vaginal Tablets/Cream Suppliers & Bulk Manufacturers
Available Forms: Vaginal Tablets/Cream
Available Strengths: 10 mg, 100 mg, 200 mg (vaginal tablets), 1% (cream)
Reference Brands: Mycelex(US); Fungusil(EU)
Category:
Anti-fungal
Clotrimazole vaginal tablets and cream inhibit fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis and damaging fungal cell membranes. They effectively treat vaginal candidiasis, offering benefits like targeted therapy, rapid symptom relief, broad antifungal activity, minimal systemic absorption, and high safety, making them a reliable choice for vaginal fungal infections.
Clotrimazole Vaginal Tablets/Cream is available in Vaginal Tablets/Cream
and strengths such as 10 mg, 100 mg, 200 mg (vaginal tablets), 1% (cream).
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Clotrimazole Vaginal Tablets/Cream is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Clotrimazole Vaginal Tablets/Cream can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Clotrimazole vaginal tablets and creams are approved in the EU and US for treating vaginal candidiasis. In the EU, brands like Canesten are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA-approved clotrimazole vaginal products, including tablets and creams, are backed by comprehensive clinical data and pharmacovigilance requirements. Both regions require detailed dossiers for approval, ensuring product safety and efficacy. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate efficient market entry for clotrimazole vaginal formulations, helping you meet European and American standards for safe, effective antifungal therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing